Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MultiplAI Health logo — MultiplAI leverages genomics and AI to provide universal rem...

MultiplAI Health

MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases.

Founded 2019 United Kingdom London, United Kingdom 11 employees Seed Total: $2.85M AI, Biopharma +3

General Information

Company Name MultiplAI Health
Founded Year 2019
Location United Kingdom London, United Kingdom +2
Employees 11
Industries AI, Biopharma, Biotechnology +2
Funding Stage Seed
Social

Get notified when MultiplAI Health moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MultiplAI Health

MultiplAI Health, founded in 2019 and headquartered in the United Kingdom, is a cutting-edge company in the intersection of AI, Biopharma, Biotechnology, and Health Care. Their innovative approach focuses on utilizing genomics and AI to revolutionize the early detection of cardiovascular and other complex diseases.

Central to their mission, expressed clearly in their slogan, “MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases,” is the development of a transformative blood screening method. Utilizing genomic RNAseq and proprietary AI analysis, MultiplAI is advancing a laboratory-validated prototype, having initiated its sixth clinical study for technical validation.

The company recently secured a $150.00K grant from HeartX on 01 September 2024 to further their research. As such, MultiplAI represents a compelling investment opportunity in the preventive medicine landscape.

Taxonomy: Preventive Medicine, Remote Screening, Cardiovascular Diseases, Genomics, AI Analysis, Liquid Biopsy, RNA Sequencing, Deep Learning, Biomarker Detection, Blood Screening, Proactive Health Management, Precision Diagnostics, Post-Treatment Monitoring, Clinical Study, Translational Medicine

Services & Products

AI-driven blood screening
RNA sequencing for disease detection
Cardiovascular disease prognostics
Cancer screening technology

Target Customers

Healthcare providers Cardiologists Patients at risk for cardiovascular diseases Medical diagnostic companies Healthcare systems and providers seeking improved diagnostic tools

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Sep 2024
Seed •••••• 3
Investor
•••• •••• 		01 Mar 2023
Grant •••••• - 01 Mar 2022
Support Program •••••• 1
Investor
01 Jul 2021
Seed •••••• 1 •••• •••• 01 Feb 2021

MultiplAI Health Alternatives & Competitors

View All Alternatives
MultiplAI Health vs
Reti Health
Reti Health United Kingdom

Preventing heart attacks and strokes with cardiovascular health screening from retinal images

Pre Seed
2-10 employees
AI, Health Care
MultiplAI Health vs
Gulf Coast Cardiology
Gulf Coast Cardiology

Comprehensive care for your cardiovascular health and internal medicine needs.

15 employees
Health Care, Health and Wellness
MultiplAI Health vs
DBS System
DBS System Switzerland

Making blood samples travel - not people.

Series A
6 employees
Health Care, Medical Devices
Also compare with: MultiplAI Health vs Stretch Smart Infrared Therapy Stretch Smart Infrared Therapy View all alternatives

FAQ About MultiplAI Health

MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases.
MultiplAI Health was founded in 2019.
MultiplAI Health is headquartered in London, United Kingdom.
MultiplAI Health operates in the following industries: AI, Biopharma, Biotechnology, Health Care, Clean Energy.
MultiplAI Health has approximately 11 employees.
MultiplAI Health has completed 5 funding rounds, raising a total of $2.85M. The latest funding stage is Seed.
MultiplAI Health offers: AI-driven blood screening, RNA sequencing for disease detection, Cardiovascular disease prognostics, Cancer screening technology.
Top alternatives and competitors to MultiplAI Health include Reti Health, Gulf Coast Cardiology, DBS System, Hongjitang, Prevencio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MultiplAI Health and Reti Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MultiplAI Health and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes